Weight-Based Dosing Best for New HCV Drug (CME/CE)

(MedPage Today) — When given in doses based on weight, an investigational prodrug of ribavirin had efficacy comparable to ribavirin in chronic hepatitis C but with less hemolytic anemia, researchers reported.

Post a Comment

Comments are closed.